Luna Health, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Luna Health, Inc. - overview
Established
2020
Location
Wilmington, DE, US
Primary Industry
Medical Devices & Equipment
About
Luna Health, Inc. is a US-based company specializing in automated insulin delivery solutions, focusing on enhancing diabetes management for insulin pen users through innovative technology and seamless user experience. Founded in 2020 in San Diego, US, Luna Health, Inc. develops solutions for diabetes management.
In August 2025, Luna Health, Inc. raised USD 23. 62 million in Series A funding led by investor Vensana Capital, with participation from investors Ascensia Diabetes Care Holdings AG, 2468 Ventures, Interlock Capital, and Winklevoss Capital. Investor Swiss Diabetes Venture Fund also participated in the round.
Luna Diabetes specializes in automated insulin delivery solutions specifically designed for users of insulin pens. Their flagship product, Luna, operates exclusively during sleep, delivering micro-boluses of insulin to maintain optimal glucose control throughout the night. This innovative technology simplifies nighttime diabetes management, providing users with a seamless experience that allows for uninterrupted rest. The primary market for Luna includes regions with high diabetes prevalence, particularly in the United States and select countries in Europe.
Luna Diabetes generates revenue through the sale of its Luna device, positioned as a direct-to-consumer product targeting individuals who use insulin pens. The business model emphasizes consumer engagement, potentially involving subscription services for ongoing support and updates related to the device. Revenue is facilitated through direct sales to consumers, enhancing the purchasing experience, with additional revenue opportunities arising from partnerships with healthcare providers and diabetes management programs. In August 2025, Luna Health, Inc.
raised USD 23. 6 mn in Series A funding to develop and test a wearable device that automatically adjusts insulin levels overnight for people with diabetes. The company plans to leverage this funding for the upcoming product launch and explore expansion into additional markets in Europe to cater to growing diabetes management needs.
Current Investors
Winklevoss Capital, Ascensia Diabetes Care Holdings AG, Vensana Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.lunadiabetes.com
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.